Status:
RECRUITING
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
University of Utah
Conditions:
Opioid Use
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigator...
Eligibility Criteria
Inclusion
- English-speaking
- age ≥18
- currently on methadone
- persistent or recurring pain that has lasted for a duration of 3 months of longer.
Exclusion
- severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
- suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
- inability to attend or fully participate in intervention sessions or assessments
- previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33 studies).
Key Trial Info
Start Date :
September 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06032559
Start Date
September 4 2023
End Date
July 31 2027
Last Update
July 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
2
University of Utah
Salt Lake City, Utah, United States, 04108